These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28401007)

  • 1. Nodal signaling activates the Smad2/3 pathway to regulate stem cell-like properties in breast cancer cells.
    Gong W; Sun B; Sun H; Zhao X; Zhang D; Liu T; Zhao N; Gu Q; Dong X; Liu F
    Am J Cancer Res; 2017; 7(3):503-517. PubMed ID: 28401007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.
    Gong W; Sun B; Zhao X; Zhang D; Sun J; Liu T; Gu Q; Dong X; Liu F; Wang Y; Lin X; Li Y
    Oncotarget; 2016 Oct; 7(43):70152-70167. PubMed ID: 27659524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
    Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
    Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells.
    Fan X; Chen W; Fu Z; Zeng L; Yin Y; Yuan H
    Oncol Lett; 2017 Nov; 14(5):5069-5076. PubMed ID: 29142594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of CD44+ALDH1+Ki-67- Cells in Non-malignant and Neoplastic Lesions of the Breast.
    DA Cruz Paula A; Marques O; Sampaio R; Rosa A; Garcia J; Rêma A; DE Fátima Faria M; Silva P; Vizcaíno R; Lopes C
    Anticancer Res; 2016 Sep; 36(9):4629-38. PubMed ID: 27630305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
    Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q
    Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Rios-Fuller TJ; Ortiz-Soto G; Lacourt-Ventura M; Maldonado-Martinez G; Cubano LA; Schneider RJ; Martinez-Montemayor MM
    Oncotarget; 2018 Nov; 9(89):35907-35921. PubMed ID: 30542507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.
    Yang F; Cao L; Sun Z; Jin J; Fang H; Zhang W; Guan X
    Int J Biol Sci; 2016; 12(12):1568-1577. PubMed ID: 27994520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis.
    Liu B; Du R; Zhou L; Xu J; Chen S; Chen J; Yang X; Liu DX; Shao ZM; Zhang L; Yu Z; Xie N; Guan JL; Liu S
    Theranostics; 2018; 8(21):5801-5813. PubMed ID: 30613263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling.
    Ruiz-Torres SJ; Benight NM; Karns RA; Lower EE; Guan JL; Waltz SE
    Oncotarget; 2017 Aug; 8(35):58918-58933. PubMed ID: 28938607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatase receptor-type δ acts as a negative regulator suppressing breast cancer.
    Yu X; Zhang F; Mao J; Lu Y; Li J; Ma W; Fan S; Zhang C; Li Q; Wang B; Song B; Li L
    Oncotarget; 2017 Nov; 8(58):98798-98811. PubMed ID: 29228728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathway.
    Fu YZ; Yan YY; He M; Xiao QH; Yao WF; Zhao L; Wu HZ; Yu ZJ; Zhou MY; Lv MT; Zhang SS; Chen JJ; Wei MJ
    Oncol Rep; 2016 Feb; 35(2):912-22. PubMed ID: 26718029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway.
    Duan W; Li R; Ma J; Lei J; Xu Q; Jiang Z; Nan L; Li X; Wang Z; Huo X; Han L; Wu Z; Wu E; Ma Q
    Oncotarget; 2015 Jan; 6(3):1490-506. PubMed ID: 25557170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?
    Shima H; Yamada A; Ishikawa T; Endo I
    Gland Surg; 2017 Feb; 6(1):82-88. PubMed ID: 28210556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanog co-regulated by Nodal/Smad2 and Oct4 is required for pluripotency in developing mouse epiblast.
    Sun LT; Yamaguchi S; Hirano K; Ichisaka T; Kuroda T; Tada T
    Dev Biol; 2014 Aug; 392(2):182-92. PubMed ID: 24929238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.